FLACS vs Standard Phacoemulsification for Cataracts
Trial Summary
What is the purpose of this trial?
The main goal of this study is to compare traditional cataract surgery with two new technologies: the femtosecond laser and the new Active Sentry handpiece. The femtosecond laser is used in several fields of ophthalmology and allows to automate multiple key steps of cataract surgery. The new generation of handpiece called Active Sentry has the particularity to detect the pressure inside the eye in real time and to adjust it to avoid large variations. Theses technologies would potentially increase the efficacy and safety of standard cataract surgery. This study therefore aims at evaluating the differences in cumulative dissipated energy and endothelial cell loss between femtosecond laser assisted cataract surgery with the new Active Sentry handpiece compared to standard phaco with new (Active Sentry) or older handpieces (OZil).
Research Team
Georges Durr, MD, FRCSC
Principal Investigator
Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria
This trial is for adults over 18 who need cataract surgery with lens implantation and can consent to participate. They must be able to attend all study visits. It's not for those under 18, unable to consent or follow-up, having additional eye surgeries, past ocular surgeries, irregular corneal astigmatism/keratoconus, or other eye diseases.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Femtosecond laser assisted cataract surgery with Active Sentry handpiece (Device)
- Standard phacoemulsification with the Active Sentry handpiece (Procedure)
- Standard phacoemulsification with the OZil handpiece (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre hospitalier de l'Université de Montréal (CHUM)
Lead Sponsor